{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:49:03Z","timestamp":1761511743579},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2001,9,1]]},"DOI":"10.1038\/sj.bmt.1703181","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T16:38:05Z","timestamp":1032280685000},"page":"435-438","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience"],"prefix":"10.1038","volume":"28","author":[{"given":"N","family":"Hanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VS","family":"Gharpure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Abonour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Cornetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PJ","family":"Loehrer Sr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,10,9]]},"reference":[{"key":"BF1703181_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2165\/00003495-199345040-00001","volume":"45","author":"PJ Loehrer","year":"1993","unstructured":"Loehrer PJ . Thymomas: current experience and future directions in therapy Drugs 1993 45: 477\u2013487","journal-title":"Drugs"},{"key":"BF1703181_CR2","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","volume":"15","author":"PJ Loehrer","year":"1997","unstructured":"Loehrer PJ, Chen M, Kim KM et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited stage, unresectable thymoma: an Intergroup Trial J Clin Oncol 1997 15: 3093\u20133099","journal-title":"J Clin Oncol"},{"key":"BF1703181_CR3","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1200\/JCO.2000.18.19.3346","volume":"18","author":"S Bhatia","year":"2000","unstructured":"Bhatia S, Abonour R, Porcu P et al. High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer J Clin Oncol 2000 18: 3346\u20133351","journal-title":"J Clin Oncol"},{"key":"BF1703181_CR4","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","volume":"14","author":"G Giaccone","year":"1996","unstructured":"Giaccone G, Ardizzoni A, Kirkpatrick A et al. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group J Clin Oncol 1996 14: 814\u2013820","journal-title":"J Clin Oncol"},{"key":"BF1703181_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","volume":"10","author":"R Simon","year":"1989","unstructured":"Simon R . Optimal two-stage designs for phase II clinical trials Cont Clin Trials 1989 10: 1\u201310","journal-title":"Cont Clin Trials"},{"key":"BF1703181_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2307\/2531294","volume":"41","author":"EN Atkinson","year":"1985","unstructured":"Atkinson EN, Brown BW . Confidence limits for probability of response in multi-stage phase II clinical trials Biomet 1985 41: 741\u2013744","journal-title":"Biomet"},{"key":"BF1703181_CR7","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","volume":"12","author":"PJ Loehrer","year":"1994","unstructured":"Loehrer PJ, Kim K, Aisner SC et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an Intergroup Trial J Clin Oncol 1994 12: 1164\u20131168","journal-title":"J Clin Oncol"},{"key":"BF1703181_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4","volume":"68","author":"A Forniasiero","year":"1991","unstructured":"Forniasiero A, Daniele O, Ghiotto C et al. Chemotherapy for invasive thymoma: a 13 year experience Cancer 1991 68: 30\u201333","journal-title":"Cancer"},{"key":"BF1703181_CR9","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/0140-6736(90)91415-7","volume":"335","author":"P Berthaud","year":"1990","unstructured":"Berthaud P, Le Chevalier T, Tursz T . Effective interleukin-2 in invasive lymphoepithelial thymoma (letter) Lancet 1990 335: 1590","journal-title":"Lancet"},{"key":"BF1703181_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00002371-199510000-00005","volume":"18","author":"MS Gordon","year":"1995","unstructured":"Gordon MS, Battiato LA, Gonin R et al. A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed\/refractory thymoma J Immuno Emph Tumor Immun 1995 18: 179\u2013184","journal-title":"J Immuno Emph Tumor Immun"},{"key":"BF1703181_CR11","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/1097-0142(19850301)55:5<1074::AID-CNCR2820550524>3.0.CO;2-T","volume":"55","author":"JM Verley","year":"1985","unstructured":"Verley JM, Hollman KH . Thymoma: a comparative study of clinical features, histologic features and survival in 200 cases Cancer 1985 55: 1074\u20131086","journal-title":"Cancer"},{"key":"BF1703181_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0167-8140(92)90227-L","volume":"24","author":"A Urgesi","year":"1992","unstructured":"Urgesi A, Monetti U, Rossi G et al. Aggressive treatment of intrathoracic recurrences of thymoma Radiother Oncol 1992 24: 221\u2013225","journal-title":"Radiother Oncol"},{"key":"BF1703181_CR13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1378\/chest.110.4.1115","volume":"110","author":"P Lara","year":"1996","unstructured":"Lara P, Bonomi P, Faber L . Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide Chest 1996 110: 1115\u20131117","journal-title":"Chest"},{"key":"BF1703181_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/00000421-199308000-00014","volume":"16","author":"PD Bonomi","year":"1993","unstructured":"Bonomi PD, Finkelstein D, Aisner S et al. EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma Am J Clin Oncol 1993 16: 342\u2013345","journal-title":"Am J Clin Oncol"},{"key":"BF1703181_CR15","first-page":"347","volume":"25","author":"S Haussen","year":"1975","unstructured":"Haussen S, Nibbelink D, Hackett E . Effect of adrenocorticosteroid therapy of myasthenia gravis on associated malignant thymomas Neurology 1975 25: 347 (Abstr.)","journal-title":"Neurology"},{"key":"BF1703181_CR16","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/1097-0142(19860315)57:6<1101::AID-CNCR2820570606>3.0.CO;2-A","volume":"57","author":"E Hu","year":"1986","unstructured":"Hu E, Levine J . Chemotherapy of malignant thymoma Cancer 1986 57: 1101\u20131104","journal-title":"Cancer"},{"key":"BF1703181_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0936-6555(05)80783-6","volume":"4","author":"C Kirkove","year":"1992","unstructured":"Kirkove C, Berghmans J, Noel H et al. Dramatic response of recurrent invasive thymoma to high-dose corticosteroid Clin Oncol 1992 4: 64\u201366","journal-title":"Clin Oncol"},{"key":"BF1703181_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1056\/NEJM199701233360405","volume":"336","author":"G Palmieri","year":"1997","unstructured":"Palmieri G, Lastoria S, Colao A et al. Successful treatment of a patient with a thymoma and pure red cell aplasia with octreotide and prednisone New Engl J Med 1997 336: 263\u2013265","journal-title":"New Engl J Med"},{"key":"BF1703181_CR19","first-page":"448a","volume":"18","author":"G Palmieri","year":"1999","unstructured":"Palmieri G, Lastoria S, Montella L et al. Phase II study of somatostatin analogs and prednisone in chemotherapy-refractory thymoma patients Proc Am Soc Clin Oncol 1999 18: 448a (Abstr.)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1703181_CR20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1378\/chest.112.2.573","volume":"112","author":"M Musi","year":"1997","unstructured":"Musi M, Di Vito F, Rosti G . Salvage chemotherapy for recurrent invasive thymoma Chest 1997 112: 572\u2013573 (letter)","journal-title":"Chest"},{"key":"BF1703181_CR21","first-page":"288","volume":"36","author":"Y Iwasaki","year":"1998","unstructured":"Iwasaki Y, Kubota Y, Yokomura I et al. Invasive thymoma successfully treated with high-dose chemotherapy followed by peripheral blood stem cell transplantation (PBSCT) Nihon Koykuki Gakkai Zasshi 1998 36: 288\u2013293","journal-title":"Nihon Koykuki Gakkai Zasshi"},{"key":"BF1703181_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/BF00273421","volume":"22","author":"MH Gaspard","year":"1988","unstructured":"Gaspard MH, Maraninchi D, Stoppa AM et al. Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies Cancer Chemo Pharmacol 1988 22: 256\u2013262","journal-title":"Cancer Chemo Pharmacol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703181","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:06:27Z","timestamp":1648073187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9,1]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,9,1]]}},"alternative-id":["BF1703181"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703181","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9,1]]},"assertion":[{"value":"8 March 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}